Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Indian Pharmaceutical Market Analysis and Forecasts 2008-2023
2.
The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
3.
Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
4.
Commercial Insight: CNS Market Overview - Commercial dynamics and outlook of the neurology, pain and psychiatry market sectors
5.
Commercial and Pipeline Insight: HRT for Menopausal Symptoms A new class restores an old market
6.
Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
7.
Pipeline Insight: Non-Small Cell Lung Cancer - Pipeline set to offer only modest improvements
8.
Stakeholder Opinions: Heart Failure - When drugs do not work
9.
Pipeline Insight: Breast Cancer - Recent approvals increase pressure on pipeline candidates
10.
Commercial and Pipeline Insight: ADHD - Immature adult market continues to offer greatest commercial potential
Best Sellers:
1.
Primary Brain Cancer
2.
Drug Delivery Global Industry Guide
3.
The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
4.
The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
5.
BioNewsCast Press Release Distribution Service
6.
Pharmaceutical Growth Opportunities in Brazil, Russia, India and China - Healthcare reform, market dynamics and key players
7.
Cell Therapy - Technologies, Markets and Companies
8.
Cytogenetics - technologies, markets and companies
9.
Molecular Diagnostics Markets
10.
The Future of Targeted Therapeutics Key technologies, new therapy area applications and leading players
Impact of Nano Materials in Drug Delivery and Human Tissue Engineering
By Gautam Thor, Ph.D.
Unprecedented levels of funding reaching tens of billions of dollars from governments, large corporations and private venture capital during the last decade, has yet to bear the fruits on the ROI. Optimistic predictions have slowly given way to the painful reality that the impact of nanotechnological applications may take one or two decades before anticipated pay offs become apparent. However, a recent analysis of more than 200 commercially available products that use nano-based technological enhancements in the pharmaceutical, medical or healthcare field is reinforcing the notion that "incremental" modifications of existing drugs, drug delivery devices and tissue engineering products enhanced by nano innovations is actually profitable and beginning to harvest revenue.
D&MD's Impact of Nano Materials in Drug Delivery & Human Tissue Engineering market analysis report provides a market driven top down approach that identifies existing products using nano based knowledge to strengthen their capabilities and provides a description of the product's market niche to pinpoint future trends.
Nano engineering and nano science are described to ensure a thorough understanding of the concepts and processes required to satisfy end user requirements with an emphasis on the growing demands. A description of potential markets, improved production and reformulations of existing drugs and next generation tissue engineered materials are also provided. Recent sales figures and financial tendencies with most of the impetus being placed in the advent of novel nano materials are referred to throughout this report.
This publication analyzes and forecasts the existing market place in the context of the "evolutionary" changes used to improve existing healthcare or medical products. The report highlights the nano science and technology involved in their creation as well as what seems to be poised to create "revolutionary" break through in future mid term and long term analyses.
Oct-06 Pages 195
Table of Contents - About the Author
Price
PDF $4,950.00
Printed $5,150.00
CD-ROM $5,150.00
Single Site Licence $6,930.00
Global Site Licence $7,425.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.